Search Results 14581-14590 of 199210 for Cancer,Cancer

  1. Tenecteplase (intravenous route) - Side effects & uses - Mayo Clinic

    The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive. ... Brain cancer or; Brain or ...

  2. Cangrelor (intravenous route) - Mayo Clinic

    Cangrelor injection is used in patients undergoing percutaneous coronary intervention (PCI) to lower the risk of blood clots and heart attack. A heart attack or ...

  3. Breast cancer - Doctors and departments - Mayo Clinic

    Analyzing the genetic makeup of breast cancer cells to understand how DNA changes affect response to cancer treatments and personalize treatment options.

  4. Breast cancer - Doctors and departments - Mayo Clinic

    Analyzing the genetic makeup of breast cancer cells to understand how DNA changes affect response to cancer treatments and personalize treatment options.

  5. Breast cancer - Doctors and departments - Mayo Clinic

    Analyzing the genetic makeup of breast cancer cells to understand how DNA changes affect response to cancer treatments and personalize treatment options.

  6. Volunteering at Mayo Clinic

    Every day, volunteers of all ages spend countless hours serving patients and visitors in key areas throughout Mayo Clinic. If you have the heart to volunteer, ...

  7. Liothyronine (oral route) - Side effects & dosage - Mayo Clinic

    It is also used to help decrease the size of enlarged thyroid glands (goiter) and treat thyroid cancer. Liothyronine is also used in some medical tests to ...

  8. Researchers resolve uncertainty in BRCA2 testing, improving cancer risk assessment and patient care - Mayo Clinic News Network

    Researchers resolve uncertainty in BRCA2 testing, improving cancer risk assessment and patient care. By. Kelley Luckstein. January 8, 2025 ...

  9. Brentuximab Vedotin and Combination Chemotherapy in Treating Younger Patients with Newly Diagnosed Hodgkin Lymphoma - Mayo Clinic

    Combinations of biological substances in brentuximab vedotin may be able to carry cancer-killing substances directly to Hodgkin lymphoma cells. Drugs used in ...

  10. Philip J. Lyng, M.D. - Doctors and Medical Staff - Mayo Clinic

    2002. Lecturer of the Month, Pulmonary Nodules and Lung CancerPulmonary Medicine Residency Program, Division of Pulmonary Medicine, Department of Internal ...